Articles dans des revues avec comité de lecture (6)
  1. 1. Sow, I. S., Gelbcke, M., Meyer, F., Vandeput, M., Marloye, M., Basov, S., Van Bael, M., Berger, G., Robeyns, K., Hermans, S., Yang, D., Fontaine, V., & Dufrasne, F. (2023). Synthesis and biological activity of iron(II), iron(III), nickel(II), copper(II) and zinc(II) complexes of aliphatic hydroxamic acids. Journal of coordination chemistry, 1-30. doi:10.1080/00958972.2023.2166407
  2. 2. Marloye, M., Inam, H., Moore, C. J., Mertens, T. R., Ingels, A., Koch, M., Nowicki, M. O., Mathieu, V., Pritchard, J. R., Awuah, S. G., Lawler, S. E., Meyer, F., Dufrasne, F., & Berger, G. (2022). Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activity. Inorganic Chemistry Frontiers. doi:10.1039/D2QI00423B
  3. 3. Marloye, M., Inam, H., Moore, C. J., Debaille, V., Pritchard, J. J., Gelbcke, M., Meyer, F., Dufrasne, F., & Berger, G. (2021). Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes. JBIC. Journal of biological inorganic chemistry. doi:10.1007/s00775-021-01873-9
  4. 4. Marloye, M., Lawler, S. E., & Berger, G. (2019). Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy. Pharmaceutical patent analyst, 8(4), 87-90. doi:10.4155/ppa-2019-0013
  5. 5. Berger, G., Marloye, M., & Lawler, S. E. (2019). Pharmacological Modulation of the STING Pathway for Cancer Immunotherapy. Trends in molecular medicine, 25(5), 412-427. doi:10.1016/j.molmed.2019.02.007
  6. 6. Marloye, M., Berger, G., Gelbcke, M., & Dufrasne, F. (2016). A survey of the mechanisms of action of anticancer transition metal complexes. Future Medicinal Chemistry, 8(18), 2263-2286. doi:10.4155/fmc-2016-0153
    7.   Communications publiées lors de congrès ou colloques nationaux et internationaux (1)
  7. 1. Marloye, M., Berger, G., Ingels, A., Meyer, F., Gelbcke, M., Mathieu, V., & Dufrasne, F. (2017). Design and synthesis of novel ruthenium(ii) and osmium(ii) complexes with potential antitumor activity. In R. Frederick, L. Pochet, P. de Tullio, & F. Dufrasne (Eds.), 31ièmes Journées Franco-Belges de Pharmacochimie: Meeting Report: Vol. 10 (4 ed., pp. 9-10) Bâle: MDPI.
    8.   Participations à des congrès et colloques internationaux (1)
  8. 1. Marloye, M., Berger, G., Ingels, A., Gelbcke, M., Mathieu, V., Debaille, V., Meyer, F., & Dufrasne, F. (2017). Preliminary biological evaluation of novel ruthenium(II) and osmium(II) complexes with potential antitumor activity. Poster présenté à la conférence PhD day Erasme (21-12-2017: Anderlecht).
    9.   Thèses et mémoires (1)
  9. 1. Marloye, M. (2021). Rationally designed ruthenium and osmium pseudo-octahedral complexes with original metabolic and antitumor properties (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Pharmacie, Bruxelles.